We describe the effects of methylenecyclopropylglycine in fasted rats. A 75 % decrease in the blood glucose concentration and an increase of lactate and pyruvate were observed 6 h after administration of 100 mg of this amino acid/kg. By contrast with the effects reported for hypoglycin [Williamson & Wilson (1965) Biochem. J. 94, 19c-21c], the plasma concentrations of ketone bodies decreased after administration of methylenecyclopropylglycine and the concentrations of branched-chain amino acids in the plasma were increased 6-fold. The oxidation of decanoylcarnitine or of palmitate was nearly completely inhibited in rat liver mitochondria from methylenecyclopropylglycine-poisoned rats. The activities of acetoacetyl-CoA and of 3-oxoacyl-CoA thiolase were decreased to 25 % and < 100 of the controls.
INTRODUCTION
Methylenecyclopropylglycine (MCPG), the lower homologue of the better-known hypoglycaemic amino acid hypoglycin (methylenecyclopropylalanine), was isolated in 1962 by Gray & Fowden and shown to be hypoglycaemic in mice [1] . It is also hypoglycaemic in fasted rats [2] . Hypoglycin is converted into its active metabolite methylenecyclopropylacetyl-CoA (MCPACoA) by the combined action of branched-chain-amino-acid aminotransferase and branched-chain-oxoacid dehydrogenase (Scheme 1). MCPA-CoA inactivates medium-chain-acyl-CoA and short-chain-acyl-CoA dehydrogenases involved in the f-oxidation of fatty acids or in the degradation of branchedchain amino acids [3] [4] [5] [6] [7] [8] [9] [10] [11] by covalent modification of the flavin prosthetic groups of the acyl-CoA dehydrogenases by a 'suicide' reaction [12] [13] [14] [15] . The pharmacological effects of hypoglycin, namely hypoglycaemia [3] , hyperketonaemia [11] and a pronounced organic aciduria [16, 17] , are the results of these inhibitions [8, 18] . By analogy with hypoglycin, it has been suggested that MCPG is converted into a toxic metabolite, methylenecyclopropylformyl-CoA (MCPF-CoA) (Scheme 1) [2, 19] . Metabolites of MCPG inhibit ,-oxidation, but at a different stage from those of hypoglycin [2] . In this work we describe the similarities and, more importantly, the differences between the effects of MCPG and of hypoglycin in fasted rats. We found that administration ofMCPG to rats causes a marked hypoketonaemia and strong inhibition of the mitochondrial 3-oxoacyl-CoA and acetoacetyl-CoA thiolases. We also provide direct evidence for the formation of MCPF-CoA from MCPG in vivo and for the formation of MCPF-CoA from methylenecyclopropylglyoxalate and MCPA-CoA from methylenecyclopropylpyruvate (MCPP) in vitro. In addition we describe a marked organic aciduria after administration of MCPG, which in part is comparable with that after the administration of hypoglycin [16, 17] .
MATERIALS AND METHODS

Materials
Hypoglycin and MCPG were isolated from dried kernels of litchi (Litchi chinensis) fruits as described by Boschert [20] . The kernels were provided by Dr. A. Munzhuber (Taipei, Taiwan), and were obtained from litchi-fruit canneries. MCPG used for animal feeding was 80 % pure and free of hypoglycin as determined by amino acid analysis. Alanine, glycine and valine were the only amino acids present as contaminants. It was assumed that they would not affect the results in the concentrations used.
MCPA-CoA was synthesized according to Wenz et al. [12] and MCPF-CoA by the method of Boschert [20] . 3-OxohexadecanoylCoA was synthesized by the method of El-Fakhri & Middleton [21] and hexadec-2,3-enoyl-CoA as described in [22] . MCPP was prepared from hypoglycin, and methylenecyclopropylglyoxalate from MCPG using L-amino-acid oxidase and catalase as described by Ruidiger et al. [23] . Decanoyl-L-carnitine and palmitoyl-L-carnitine were synthesized and characterized as described by Holland & Sherratt [24] . L-Carnitine was a gift from Sigma Tau, Rome, Italy. All blood was obtained by cardiac puncture. The livers were removed and mitochondrial fractions prepared as described below.
Standard Methods
Plasma glucose, lactate, pyruvate, acetoacetate anL 3-hydroxybutyrate concentrations were determined as described by Lloyd et al. [25] . The plasma concentrations of free amino acids were determined as described by Goodman & Vale [26] , using a Biotronix amino acid analyser. Protein concentrations were determined as described by Lowry et al. [27] , with BSA as standard. Statistical significances of the differences between means were calculated by Student's t test (*P < 0.05; **P < 0.01; ***P < 0.005). Owing to the wide range of the amounts of the organic acid extracts and of free amino acids in the plasma, no tests for significance were performed for these values.
Measurement of mitochondrialp-oxidation
Mitochondrial fractions were prepared in 0.3M-sucrose/ 10 mM-Hepes/1 mM-EGTA, pH 7.2, and their 02 uptake, as determined polarographically at 30°C, as. described by Van Hoof et al. [18] . 20,tM-Decanoylcarnitine, 10 mM-glutamate plus 1 [29] . The activities of long-chain-specific (LC-) and shortchain-specific (SC-)3-hydroxyacyl-CoA dehydrogenases were measured and calculated as described by El-Fakhri & Middleton [21] . The activities of LC-and SC-enoyl-CoA hydratases were determined by monitoring the decrease of A263 due to the reduction of the double bond of hexadec-2,3-enoyl-CoA and crotonyl-CoA. A molar absorption coefficient of 15400 M-1' cm-' was used [22] . Acyl-CoA dehydrogenases were measured by using dichlorophenol-indophenol and phenazine methosulphate as artificial electron acceptors as described by Veitch et al. [17] .
Branched-chain-amino-acid aminotransferase activities were measured [30] Watmough et al. [31] . Acyl-CoA esters were eluted from the column (Lichrosorb 10-RP18; 250 mm x 4.6 mm) by a gradient of methanol in water containing 50 mM-KH2PO4, pH 5.3, using the conditions described by Causey et al. [32] . MCPF-CoA had a retention time of 48.23 min and was co-eluted with an unidentified peak with a retention time of 47.82 min. MCPF-CoA was therefore purified further [31] and identified. MCPF-CoA was absent from extracts of mitochondria from control rats. In addition, the formation of MCPF-CoA was demonstrated in mitochondria from control rats incubated with methylenecyclopropylglyoxalate. Mitochondria (20 mg of protein) were incubated at 30°C in a shaking water bath (120 strokes/min) in 2 ml of medium containing 100 mM-KCl, 2.5 mM-KH2PO4, 5 mM-MgCl2, I mm-EDTA, 5 mM-ATP, 0.1 mM-CoA, 0.5 mM-carnitine, 40 /M-2,4-dinitrophenol, pH 7.2 [31] . After 3 min preincubation, 20 #M-methylenecyclopropylglyoxalate was added and incubated for 5 min, the reaction stopped by addition of 200,1u of 5M-HC104 and then treated as described above and analysed by h.p.l.c. The formation of MCPA-CoA was also demonstrated in mitochondria incubated with MCPP (Fig. 3, below) . 
and left at room temperature for at least 30 min. The methylated extracts were analysed by g.l.c.-m.s. using the system and conditions described by Veitch et al. [17] .
reversible enzyme inhibitions by high concentrations of metabolites in the mitochondrial matrix would not have been detected. The strong inhibition of mitochondrial fl-oxidation after administration of MCPG can be explained by inactivation of RESULTS AND DISCUSSION Effects of MCPG on blood metabolites Administration of MCPG (100 mg/kg body wt.) to 24 hfasted rats caused a 72 % decrease in plasma glucose concentrations after 4 h ( Table 1 ). There were small increases in lactate and pyruvate, with a change in the lactate/pyruvate ratio from 20 to 9. Acetoacetate and 3-hydroxybutyrate concentrations were lowered to less than 0.01 mM ( Table 1 ). The plasma concentrations of most amino acids were increased (Table 1) ; the largest changes were increases in the branched-chain amino acids (500-550 %) and the basic amino acids (200-260 %) ( Table 1 ).
Effects of methylenecyclopropylglyoxalate on mitochondrial oxidations There was no inhibition of the oxidation of 10 mM-succinate or of 10 mM-glutamate plus 1 mM-malate, and there was no effect on the stimulation of State 3 respiration by 10 1tM-ADP, in mitochondria preincubated for 3 min with 10 ,tM-methylenecylcopropylglyoxalate, or in mitochondria from MCPG-treated rats (results not shown). This indicates that metabolites of MCPG have little effect on the citrate cycle, the respiratory chain or oxidative phosphorylation.
No oxidation of 10 #M-decanoylcarnitine was detected in coupled or uncoupled liver mitochondria from MCPG-treated rats, although 10 /M-decanoylcarnitine was rapidly and completely oxidized to acetoacetate by the controls (Fig. 1) . The oxidation of decanoylcarnitine was also completely suppressed in uncoupled mitochondria from control rats after 3 min preincubation with O1/uM-methylenecyclopropylglyoxalate.
Similar results were obtained when 10 /LM-palmitoylcarnitine was used as substrate (results not shown). There was no inhibition of the oxidation of 10 ,aM-decanoylcarnitine in normal mitochondria that had been incubated for 3 min with 20 ,tM-MCPG, or with 20 ,#M-MCPF-CoA plus 0.5 mM-carnitine, indicating that MCPFCoA cannot cross the mitochondrial inner membrane directly and that it is not a substrate for the carnitine palmitoyltransferases.
Activities of enzymes of fp-oxidation and some enzymes involved in the degradation of branched-chain amino acids 3-Oxoacyl-CoA and acetoacetyl-CoA thiolases are the major targets in the ,-oxidation pathway for the toxic metabolites of MCPG (Table 2) . Their activities were depressed to less than 10 % and about 25 % respectively of those in the controls. That the inhibition of the thiolases persisted in the final assay medium when the matrix contents had been diluted approx. 100000-fold indicates that the inhibition was irreversible or that MCPF-CoA has a very high affinity for these enzymes. In addition, the activities of the two chain-length-specific 3-hydroxyacyl-CoA dehydrogenases were decreased to 73 and 60 % of control values. The two chain-length-specific enoyl-CoA hydratases and, as reported previously [2] , the three acyl-CoA dehydrogenases of the f8-oxidation pathway, are not inhibited significantly in liver mitochondria from MCPG-treated rats. By contrast, the two acyl-CoA dehydrogenases involved in the degradation of branched-chain amino acids are both inhibited: 2-(methyl)-branched-chain acyl-CoA dehydrogenase to 70 % of the control values and isovaleryl-CoA dehydrogenase to 40 % respectively, confirming our earlier observations [2] . Branched-chain-aminoacid aminotransferase was also inhibited by 50 % ( Vol. 274 butyryl-CoA, 0.70; MCPF-CoA, 0.78; MCPA-CoA, 0.87; and Table 3 . Effects of administration of MCPG to fasted rats on the excretion of organic acids and glycine conjugates Urine was collected and analysed after the administration of MCPG (100 mg/kg body wt.) or 0.14 M-NaCl to 24 h-fasted rats as described in the Materials and methods section. The results are expressed as g/mol of creatinine, determined by a standard alkaline picrate method, and are means + S.E.M. for three animals. *, Metabolite not detected. hexanoyl-CoA, 1 .00. The absence of other short-chain acyl-CoA esters is consistent with the inhibition of long-chain-fatty-acid oxidation at the stage of 3-oxoacyl-CoA thiolase. Treatment of extracts with 2 M-KOH for 60 min at 55°C caused complete loss of all peaks identified as CoA esters (results not shown). This, taken together with the spectral and chromatographic data, strongly suggests that these peaks were CoA-esters. Fig. 3 shows typical chromatograms for mitochondria from control and MCPP-treated animals. In extracts of mitochondria incubated with MCPP, an additional peak with a retention time of 58.80 min (relative retention time 0.87) with the typical spectrum of a CoA ester was detected, and it was concluded that this was MCPA-CoA. In addition, there was a high concentration of butyryl-CoA (retention time 42.53 min; 0.70), consistent with the known inhibition of butyryl-CoA dehydrogenase by MCPA-CoA [7, 18] .
The finding that MCPG has no effect on fl-oxidation in isolated mitochondria, but that methylenecyclopropylglyoxalate is strongly inhibitory, also indicates that MCPG must first be converted into an active metabolite in vivo. Therefore it can be assumed that MCPG is metabolized in the cytosol to methylenecyclopropylglyoxalate, which is then oxidatively decarboxylated in the mitochondrial matrix to MCPF-CoA, by analogy with hypoglycin [8] (Scheme 1).
MCPF-CoA only differs chemically from MCPA-CoA by the absence of a methylene group. This may weaken binding to the active sites of medium-chain acyl-CoA and butyryl-CoA dehydrogenases compared with MCPA-CoA, so that a-proton abstraction leading to suicide inhibition is impaired [12] . The proximity of the carbonyl group of MCPF-CoA to the methylenecyclopropyl ring may activate the methylene group so that it can undergo nucleophilic attack by thiol groups of the thiolases required for catalytic activity with the formation of an inactive adduct. 
1991
Mechanism of the metabolic disturbances caused by MCPG
The profound hypoglycaemia caused by MCPG in fasted rats whose hepatic glycogen stores have been depleted (Table 1) can be attributed to inhibition of fatty acid oxidation. In the liver, inhibition off-oxidation decreases gluconeogenesis by decreasing the supply of NADH, which is required for glucose synthesis from many precursors, and of acetyl-CoA, which allosterically activates pyruvate carboxylase necessary for glucose synthesis from pyruvate and other precursors which are first converted into pyruvate [41] . Any inhibition of fl-oxidation in extrahepatic tissues might be expected to increase glucose utilization and contribute to hypoglycaemia [42] . However, in hypoglycintreated rats, glucose disposal is actually decreased, but to a lesser extent than gluconeogenesis [43] .
Inactivation of acetoacetyl-CoA thiolase in liver can explain the suppression of ketogenesis by MCPG (Table 1) , since this enzyme is involved in the synthesis of acetoacetate from acetylCoA. Acetyl-CoA is formed by f-oxidation, and to a lesser extent by the oxidation of pyruvate and some amino acids. By contrast there is marked hyperketonaemia in hypoglycin-treated rats [11] . This has been attributed to an even greater inhibition of the extrahepatic oxidation of ketone bodies than of their formation by the liver [7, 11] . Inhibition of MC-acyl-CoA and Conditions of incubation and analysis were as described in the Materials and methods section. The relative retention times were as follows: (1) butyryl-CoA, 0.70; (2) unidentified; (3) methylenecyclopropylacetyl-CoA; (4) hexanoyl-CoA (internal standard), 1.00.
SC-acyl-CoA dehydrogenases, but not LC-acyl-CoA dehydrogenase, by hypoglycin metabolites inhibits the maximum rate of mitochondrial f-oxidation of long-chain fatty acids by about 50% and which then only proceeds as far as butyrate, with continuous recycling of CoA required for this limited oxidation [6] [7] [8] 35, 36] .
The large increases in the concentrations of the branchedchain amino acids in plasma caused by MCPG can be attributed to inhibition of their degradation, probably at the stage of branched-chain-amino-acid transferase (Tables 1 and 2 ). There may also be some inhibition at the stage of branchedchain-acyl-CoA dehydrogenase (Table 2 ). This contrasts with the lack of such changes after administration of hypoglycin [26] , which inhibits the degradation of branched-chain amino acids mainly at the stage of dehydrogenation of isovaleryl-CoA, 2-methylbutyryl-CoA or isobutyryl-CoA [16] (Scheme 1), but not at the level of the aminotransferases [44] . However, MCPG metabolites also inhibit isovaleryl-CoA dehydrogenase by 40 % and 2-methylbutyryl-CoA dehydrogenase by 70 % ( Table 2) .
Effects of MCPG on urinary organic acids
Few organic acids except benzoylglycine (hippuric acid) were detected in urine from the control rats. By contrast, there was a marked organic aciduria in MCPG-treated rats (Table 3) . Some monocarboxylic acids were identified were 3-hydroxyisovaleric acid, 2-methyl-3-hydroxybutanoic acid and 3-hydroxybutanoic acid. Dicarboxylic acids detected were: hexane-1,6-dioic acid, heptane-1,7-dioic acid, octane-1,8-dioic acid, nonane-1,9-dioic acid, undecane-1,1 -dioic acid, dodecane-1, 12-dioic acid and hexadecane-1,1 6-dioic acid. Isovalerylglycine, 2-methylbutyrylglycine and benzoylglycine were also identified. Administration of MCPG to fasted rats causes a marked organic aciduria (Table 3) . Long-chain fatty acids accumulate because of inhibition of f-oxidation (Scheme 1). These are oxidized to o-dicarboxylic acids in the endoplasmic reticulum, where they are converted into their mono-CoA esters, which then undergo fl-oxidation to shorter-chain dicarboxylic acids in the peroxisomes (presumably either the specific peroxisomal thiolase [45] is not inhibited or metabolites of MCPG are not formed in peroxisomes) [46, 47] . Some free acids and glycine conjugates derived from the degradation of the branched-chain amino acids were also created (Table 3 ), corresponding to inhibition at the stage of the branched-chain-acyl-CoA dehydrogenases. Hypoglycin also causes a massive organic aciduria, but the pattern of metabolites differs from that caused by MCPG with large amounts of some unsaturated dicarboxylic acids and relatively more metabolites of branched-chain amino acids [16] .
Conclusions
There has been little interest in the metabolic effects of MCPG since its discovery nearly 30 years ago [1] , because it was assumed to have a similar mechanism of action to that of hypoglycin. However, the present investigation has revealed that, although there are some similarities, there are also marked differences. Both are powerfully hypoglycamic and appear to be converted into active metabolites by very similar pathways (Scheme 1). MCPG is strongly hypoketonaemic but, by contrast, hypoglycin is hyperketonaemic in fasted rats.
